Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas-A Preliminary Study.

Karolina SkubiszKrzysztof DąbkowskiEmilia SamborowskaTeresa StarzyńskaAnna DeskurFilip Ambrozkiewicz Jakub Karczmarski Mariusz Radkiewicz Katarzyna KusnierzBeata Kos-KudłaTadeusz SulikowskiPatrycja CybulaAgnieszka Paziewska

Published in: Cancers (2023)

The observations presented provide better insight into the metabolism of pancreatic tumors, and improve the diagnosis and classification of tumors. Serum-circulating metabolites can be easily monitored without invasive procedures and show the present clinical patients' condition, helping with pharmacological treatment or dietary strategies.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
machine learning
ms ms
deep learning
prognostic factors
replacement therapy
smoking cessation